Connect with us
Spanish pharmaceutical stocks dropped 10% in November, led by Rovi's 17.5% plunge amid profit and turnover declines. Grifols also fell 16%, impacted by OPA cancellation and...
Spanish pharmaceutical companies had mixed results: Almirall and Reig Jofre shares dropped by 4% and 2.5%, respectively, while Faes Farma and PharmaMar saw increases of around...
According to the results presented by the pharmaceutical giants to the National Securities Commission (CNMV), the revenues of these five companies also rose in the first...
Reig Jofre is the only one that does not follow the upward trend of the Spanish pharmaceutical sector and closes the third quarter with a decrease...
The six listed pharmaceutical companies closed the first quarter with a stock market value of €9.5 billion, compared to €10.6 billion at the close of the...
Pharma Mar has decided to liquidate its diagnostic subsidiary Genomics, as part of their strategy to focus on their core activity of drug development and marketing....
Pharma Mar has other programs in the clinical development phase for various types of solid tumors: lurbinectedin, and ecubectedin. Headquartered in Madrid, the group has subsidiaries...
Reig Jofre reported a profit of €4.2 million between January and September 2022, 16% less than in the same period of 2021. The company justifies this...
Grifols and Pharma Mar reduced profits, while Reig Jofre, Faes Farma, Rovi and Almirall increased their profits between January and June. This last company has exceeded...
Rovi's increase was mainly driven by the strength of the third-party manufacturing business, which grew by 167%. Farma posted a net profit of $28 million (€26.6...